Cargando…
Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination
Glioma cells release exosomes in culture and into the extracellular matrix in vivo. These nanobodies transport an array of biomolecules and are capable of mediating cell-cell communication. Circulating exosomes in cancer patients may be indicative of disease status and response to therapy. The inhib...
Autores principales: | Galbo, Phillip M., Ciesielski, Michael J., Figel, Sheila, Maguire, Orla, Qiu, Jingxin, Wiltsie, Laura, Minderman, Hans, Fenstermaker, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777727/ https://www.ncbi.nlm.nih.gov/pubmed/29383115 http://dx.doi.org/10.18632/oncotarget.21773 |
Ejemplares similares
-
Wild type, dEX3 and 2B survivin isoforms localize to the tumor cell plasma membrane, are secreted in exosomes, and interact with extracellular tubulin
por: Figel, Sheila, et al.
Publicado: (2021) -
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
por: Fenstermaker, Robert A., et al.
Publicado: (2016) -
Exploring the role of survivin in neuroendocrine neoplasms
por: Hanif, Ahmad, et al.
Publicado: (2020) -
Exosomal survivin facilitates vesicle internalization
por: Gonda, Amber, et al.
Publicado: (2018) -
Survivin and gliomas: A literature review
por: Varughese, Rosilin Kotakkathu, et al.
Publicado: (2016)